Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxine Sun

Showing results (1-10 of 401) with videos related to

Pageof 41
Sort By:
Nature Reviews. Urology|December 19, 2013
Bladder cancer: Conditional survival after radical cystectomyGiorgio Gandaglia, Maxine Sun
European Urology|June 20, 2015
Re: AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate CancerMaxine Sun, Firas Abdollah
BJU International|July 21, 2015
A Surveillance, Epidemiology and End Results (SEER) database malfunction: perceptions, pitfalls and veritiesMaxine Sun, Quoc-Dien Trinh
European Urology|September 3, 2014
Reply to Marc Bjurlin, Elena Elkin, and William Huang's Letter to the Editor re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol 2014;65:235-41Maxine Sun, Pierre I Karakiewicz
JAMA|January 3, 2013
Statistical analysis plans in observational researchQuoc-Dien Trinh, Maxine Sun
Nature Reviews. Urology|April 1, 2016
Kidney cancer: Recurrence in renal cell carcinoma: the work is not doneMaxine Sun, Toni K Choueiri
Urologic Oncology|November 18, 2017
Comparative effectiveness research methodology using secondary data: A starting user's guideMaxine Sun, Stuart R Lipsitz
Urology|June 2, 2010
Editorial commentPierre I Karakiewicz, Maxine Sun
Hematology/Oncology Clinics of North America|April 4, 2015
Diagnosis and staging of bladder cancerMaxine Sun, Quoc-Dien Trinh
Cancer|December 19, 2013
Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?Andreas Becker, Christian Eichelberg, Maxine Sun
Pageof 41

Showing results (1-10 of 401) with videos related to

Sort By:
Pageof 41
Nature Reviews. Urology|December 19, 2013
Bladder cancer: Conditional survival after radical cystectomyGiorgio Gandaglia, Maxine Sun
European Urology|June 20, 2015
Re: AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate CancerMaxine Sun, Firas Abdollah
BJU International|July 21, 2015
A Surveillance, Epidemiology and End Results (SEER) database malfunction: perceptions, pitfalls and veritiesMaxine Sun, Quoc-Dien Trinh
European Urology|September 3, 2014
Reply to Marc Bjurlin, Elena Elkin, and William Huang's Letter to the Editor re: Maxine Sun, Andreas Becker, Zhe Tian, et al. Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol 2014;65:235-41Maxine Sun, Pierre I Karakiewicz
JAMA|January 3, 2013
Statistical analysis plans in observational researchQuoc-Dien Trinh, Maxine Sun
Nature Reviews. Urology|April 1, 2016
Kidney cancer: Recurrence in renal cell carcinoma: the work is not doneMaxine Sun, Toni K Choueiri
Urologic Oncology|November 18, 2017
Comparative effectiveness research methodology using secondary data: A starting user's guideMaxine Sun, Stuart R Lipsitz
Urology|June 2, 2010
Editorial commentPierre I Karakiewicz, Maxine Sun
Hematology/Oncology Clinics of North America|April 4, 2015
Diagnosis and staging of bladder cancerMaxine Sun, Quoc-Dien Trinh
Cancer|December 19, 2013
Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?Andreas Becker, Christian Eichelberg, Maxine Sun
Pageof 41